| Budget Amount *help |
¥17,680,000 (Direct Cost: ¥13,600,000、Indirect Cost: ¥4,080,000)
Fiscal Year 2017: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2016: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2015: ¥7,540,000 (Direct Cost: ¥5,800,000、Indirect Cost: ¥1,740,000)
|
|---|
| Outline of Final Research Achievements |
Tuberculosis remains to be a global threat to humans. The only currently available anti-tuberculosis vaccine, BCG, has been used for decade, but development of alternative vaccines is definitely required. The principal investigator has attempted to develop a new type of lipid-based vaccines against tuberculosis. In this study, the vaccine candidate lipid was studied extensively in terms of is biosynthesis as well as its immunological properties. The findings obtained in this study provide an important basis for the development of anti-tuberculosis lipid vaccines.
|
